Home Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities
Article
Licensed
Unlicensed Requires Authentication

Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities

  • John E. Bylander , Greg P. Bertenshaw , Gail L. Matters , Simon J. Hubbard and Judith S. Bond
Published/Copyright: November 2, 2007
Biological Chemistry
From the journal Volume 388 Issue 11

Abstract

Meprin metalloproteinases have been implicated in the susceptibility to and progression of diabetic nephropathy and inflammatory bowel diseases. Our studies with experimental models of these diseases in mice are congruent with the conclusion that meprins modulate the inflammatory responses and tissue damage. To determine whether the mouse and human enzymes differ, recombinant forms of meprin A from the two species were compared with respect to structure, substrates and inhibitors. Human homo-oligomeric meprin A formed oligomers ranging from 950 000 to 1 500 000 Da vs. 900 000 Da for mouse meprin A. Human and mouse meprin A exhibited similar activity against azocasein, fibronectin, collagen IV, and peptides such as parathyroid hormone, ghrelin, and gastrin-releasing peptide. The human enzyme had lower activity against gelatin, bradykinin, α-melanocyte-stimulating hormone and neurotensin, and higher activity against secretin and orcokinin. Human meprin A showed a preference for acidic residues in the P1′ position of the substrate, unlike mouse meprin A. Several metalloproteinase inhibitors had IC50 values in the nanomolar range, but potency ranged from similar values to a difference of several orders of magnitude for meprins from the two species. This work provides valuable data to improve predictability for human systems based on meprin functions in mouse models.


Corresponding author

Received: 2007-6-13
Accepted: 2007-8-20
Published Online: 2007-11-02
Published in Print: 2007-11-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Proteinase Inhibitors and Biological Control – An Attractive International Symposia Series
  2. Two decades of thyroglobulin type-1 domain research
  3. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function
  4. Cysteine proteases: destruction ability versus immunomodulation capacity in immune cells
  5. ‘Species’ of peptidases
  6. Protease research in the era of systems biology
  7. Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities
  8. Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses
  9. Characterization and comparative 3D modeling of CmPI-II, a novel ‘non-classical’ Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca)
  10. Cellular localization of MAGI-1 caspase cleavage products and their role in apoptosis
  11. Differential methylation kinetics of individual target site strands by T4Dam DNA methyltransferase
  12. Characterisation of zinc-binding domains of peroxisomal RING finger proteins using size exclusion chromatography/inductively coupled plasma-mass spectrometry
  13. Defining the extended substrate specificity of kallikrein 1-related peptidases
  14. Latent MMP-9 is bound to TIMP-1 before secretion
  15. Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma
  16. Activity of ulilysin, an archaeal PAPP-A-related gelatinase and IGFBP protease
  17. Clinical chemistry reference database for Wistar rats and C57/BL6 mice
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2007.156/html
Scroll to top button